-DOCSTART- -X- O
OBJECTIVES -X- _ O
: -X- _ O
The -X- _ O
role -X- _ O
of -X- _ O
bacteria -X- _ O
in -X- _ O
acute -X- _ B-Patient
respiratory -X- _ I-Patient
illnesses -X- _ I-Patient
( -X- _ I-Patient
ARI -X- _ I-Patient
) -X- _ I-Patient
of -X- _ I-Patient
adults -X- _ I-Patient
and -X- _ O
interactions -X- _ O
with -X- _ O
viral -X- _ O
infections -X- _ O
is -X- _ O
incompletely -X- _ O
understood. -X- _ O
This -X- _ O
study -X- _ O
tested -X- _ O
the -X- _ O
hypothesis -X- _ O
that -X- _ O
bacterial -X- _ B-Patient
co-infection -X- _ I-Patient
during -X- _ I-Patient
ARI -X- _ I-Patient
adds -X- _ O
to -X- _ O
airway -X- _ O
inflammation -X- _ O
and -X- _ O
illness -X- _ O
severity. -X- _ O
METHODS -X- _ O
: -X- _ O
Two -X- _ O
groups -X- _ O
of -X- _ O
97 -X- _ B-Patient
specimens -X- _ I-Patient
each -X- _ O
were -X- _ O
randomly -X- _ O
selected -X- _ O
from -X- _ O
multiplex-PCR -X- _ O
identified -X- _ O
virus-positive -X- _ O
and -X- _ O
virus-negative -X- _ O
nasal -X- _ O
specimens -X- _ O
obtained -X- _ O
from -X- _ O
adults -X- _ O
with -X- _ O
new -X- _ O
onset -X- _ O
ARI -X- _ O
, -X- _ O
and -X- _ O
40 -X- _ B-Comparison
control -X- _ I-Comparison
specimens -X- _ I-Comparison
were -X- _ O
collected -X- _ O
from -X- _ O
healthy -X- _ O
adults. -X- _ O
All -X- _ O
specimens -X- _ O
were -X- _ O
analyzed -X- _ O
for -X- _ O
Haemophilus -X- _ B-Patient
influenza -X- _ I-Patient
( -X- _ I-Patient
HI -X- _ I-Patient
) -X- _ I-Patient
, -X- _ I-Patient
Moraxella -X- _ I-Patient
catarrhalis -X- _ I-Patient
( -X- _ I-Patient
MC -X- _ I-Patient
) -X- _ I-Patient
and -X- _ I-Patient
Streptococcus -X- _ I-Patient
pneumonia -X- _ I-Patient
( -X- _ I-Patient
SP -X- _ I-Patient
) -X- _ I-Patient
by -X- _ O
quantitative-PCR. -X- _ O
General -X- _ O
linear -X- _ O
models -X- _ O
tested -X- _ O
for -X- _ O
relationships -X- _ O
between -X- _ O
respiratory -X- _ O
pathogens -X- _ O
, -X- _ O
biomarkers -X- _ O
( -X- _ O
nasal -X- _ O
wash -X- _ O
neutrophils -X- _ O
and -X- _ O
CXCL8 -X- _ O
) -X- _ O
, -X- _ O
and -X- _ O
ARI-severity. -X- _ O
RESULTS -X- _ O
: -X- _ O
Nasal -X- _ B-Outcome
specimens -X- _ I-Outcome
from -X- _ I-Outcome
adults -X- _ I-Outcome
with -X- _ I-Outcome
ARIs -X- _ I-Outcome
were -X- _ I-Outcome
more -X- _ I-Outcome
likely -X- _ I-Outcome
to -X- _ I-Outcome
contain -X- _ I-Outcome
bacteria -X- _ I-Outcome
( -X- _ I-Outcome
37 -X- _ I-Outcome
% -X- _ I-Outcome
overall -X- _ I-Outcome
; -X- _ I-Outcome
HI=28 -X- _ I-Outcome
% -X- _ I-Outcome
, -X- _ I-Outcome
MC=14 -X- _ I-Outcome
% -X- _ I-Outcome
, -X- _ I-Outcome
SP=7 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
compared -X- _ I-Outcome
to -X- _ I-Outcome
specimens -X- _ I-Outcome
from -X- _ I-Outcome
healthy -X- _ I-Outcome
adults -X- _ I-Outcome
( -X- _ I-Outcome
5 -X- _ I-Outcome
% -X- _ I-Outcome
overall -X- _ I-Outcome
; -X- _ I-Outcome
HI=0 -X- _ I-Outcome
% -X- _ I-Outcome
, -X- _ I-Outcome
MC=2.5 -X- _ I-Outcome
% -X- _ I-Outcome
, -X- _ I-Outcome
SP=2.5 -X- _ I-Outcome
% -X- _ I-Outcome
; -X- _ I-Outcome
p -X- _ I-Outcome
< -X- _ I-Outcome
0.001 -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
Among -X- _ I-Outcome
ARI -X- _ I-Outcome
specimens -X- _ I-Outcome
, -X- _ I-Outcome
bacteria -X- _ I-Outcome
were -X- _ I-Outcome
more -X- _ I-Outcome
likely -X- _ I-Outcome
to -X- _ I-Outcome
be -X- _ I-Outcome
detected -X- _ I-Outcome
among -X- _ I-Outcome
virus-negative -X- _ I-Outcome
specimens -X- _ I-Outcome
compared -X- _ I-Outcome
to -X- _ I-Outcome
virus-positive -X- _ I-Outcome
specimens -X- _ I-Outcome
( -X- _ I-Outcome
46 -X- _ I-Outcome
% -X- _ I-Outcome
vs. -X- _ I-Outcome
27 -X- _ I-Outcome
% -X- _ I-Outcome
; -X- _ I-Outcome
p=0.0046 -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
The -X- _ I-Outcome
presence -X- _ I-Outcome
of -X- _ I-Outcome
bacteria -X- _ I-Outcome
was -X- _ I-Outcome
significantly -X- _ I-Outcome
associated -X- _ I-Outcome
with -X- _ I-Outcome
increased -X- _ I-Outcome
CXCL8 -X- _ I-Outcome
and -X- _ I-Outcome
neutrophils -X- _ I-Outcome
, -X- _ I-Outcome
but -X- _ I-Outcome
not -X- _ I-Outcome
increased -X- _ I-Outcome
symptoms. -X- _ I-Outcome
CONCLUSION -X- _ O
: -X- _ O
Pathogenic -X- _ B-Outcome
bacteria -X- _ I-Outcome
were -X- _ I-Outcome
more -X- _ I-Outcome
often -X- _ I-Outcome
detected -X- _ I-Outcome
in -X- _ I-Outcome
virus-negative -X- _ I-Outcome
ARI -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
also -X- _ I-Outcome
associated -X- _ I-Outcome
with -X- _ I-Outcome
increased -X- _ I-Outcome
inflammatory -X- _ I-Outcome
biomarkers. -X- _ I-Outcome
These -X- _ O
findings -X- _ O
suggest -X- _ O
the -X- _ O
possibility -X- _ O
that -X- _ O
bacteria -X- _ O
may -X- _ O
augment -X- _ O
virus-induced -X- _ O
ARI -X- _ O
and -X- _ O
contribute -X- _ O
to -X- _ O
airway -X- _ O
inflammation. -X- _ O
SUMMARY -X- _ O
: -X- _ O
We -X- _ O
tested -X- _ O
whether -X- _ O
bacterial -X- _ O
pathogens -X- _ O
were -X- _ O
associated -X- _ O
with -X- _ O
ARI -X- _ O
illness -X- _ O
and -X- _ O
inflammation. -X- _ O
Bacteria -X- _ B-Outcome
were -X- _ I-Outcome
detected -X- _ I-Outcome
more -X- _ I-Outcome
often -X- _ I-Outcome
in -X- _ I-Outcome
nasal -X- _ I-Outcome
secretions -X- _ I-Outcome
during -X- _ I-Outcome
ARI -X- _ I-Outcome
, -X- _ I-Outcome
especially -X- _ I-Outcome
in -X- _ I-Outcome
samples -X- _ I-Outcome
without -X- _ I-Outcome
detectable -X- _ I-Outcome
viruses -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
were -X- _ I-Outcome
associated -X- _ I-Outcome
with -X- _ I-Outcome
increased -X- _ I-Outcome
airway -X- _ I-Outcome
inflammation -X- _ I-Outcome
, -X- _ I-Outcome
but -X- _ I-Outcome
not -X- _ I-Outcome
increased -X- _ I-Outcome
symptoms -X- _ I-Outcome
. -X- _ O

